- Home
- RCKT vs SOR Comparison
RCKT vs SOR Comparison
Compare RCKT & SOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- SOR
- Stock Information
- Founded
- RCKT 1999
- SOR 1968
- Country
- RCKT United States
- SOR United States
- Employees
- RCKT N/A
- SOR N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- SOR Investment Managers
- Sector
- RCKT Health Care
- SOR Finance
- Exchange
- RCKT Nasdaq
- SOR Nasdaq
- Market Cap
- RCKT 328.6M
- SOR 364.9M
- IPO Year
- RCKT N/A
- SOR N/A
- Fundamental
- Price
- RCKT $3.28
- SOR $44.50
- Analyst Decision
- RCKT Buy
- SOR
- Analyst Count
- RCKT 13
- SOR 0
- Target Price
- RCKT $12.96
- SOR N/A
- AVG Volume (30 Days)
- RCKT 6.0M
- SOR 16.2K
- Earning Date
- RCKT 08-07-2025
- SOR 01-01-0001
- Dividend Yield
- RCKT N/A
- SOR 7.24%
- EPS Growth
- RCKT N/A
- SOR N/A
- EPS
- RCKT N/A
- SOR 6.50
- Revenue
- RCKT N/A
- SOR N/A
- Revenue This Year
- RCKT N/A
- SOR N/A
- Revenue Next Year
- RCKT $108.43
- SOR N/A
- P/E Ratio
- RCKT N/A
- SOR $6.41
- Revenue Growth
- RCKT N/A
- SOR N/A
- 52 Week Low
- RCKT $2.19
- SOR $36.41
- 52 Week High
- RCKT $22.01
- SOR $42.75
- Technical
- Relative Strength Index (RSI)
- RCKT 51.17
- SOR 63.93
- Support Level
- RCKT $2.88
- SOR $43.65
- Resistance Level
- RCKT $3.74
- SOR $44.86
- Average True Range (ATR)
- RCKT 0.27
- SOR 0.63
- MACD
- RCKT 0.02
- SOR 0.05
- Stochastic Oscillator
- RCKT 35.43
- SOR 68.46
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About SOR Source Capital Inc.
Source Capital Inc is a diversified, closed-end management investment company. The investment objective of the company is to seek maximum total return for Common shareholders from both capital appreciation and investment income to the extent consistent with the protection of invested capital.